Sparta Biomedical Closes an Oversubscribed Convertible Round to Advance its Breakthrough Device
Sparta Biomedical, a Duke start-up and Duke Capital Partners portfolio company, was founded around technology developed by lead inventor Professor Benjamin Wiley (Chemistry, Trinity), along with Professor Ken Gall (MEMS, Pratt), Professor Matt Becker (Chemistry,…
NCBiotech Awards $2.75 Million in Grants, Loans in Latest Quarter
Two Duke start-ups received loans & four Duke projects received Translational Research Grants. Recipients hail from across the university!
Sparta Biomedical Celebrates Prestigious Recognition in MedTech and Significant Milestone
Sparta Biomedical, a Duke start-up and Duke Capital Partners portfolio company, was founded around technology developed by lead inventor Professor Benjamin Wiley (Chemistry, Trinity), along with Professor Ken Gall (MEMS, Pratt), Professor Matt Becker (Chemistry,…
Precision BioSciences Completes Strategic Transaction with Imugene for Azer-Cel in Cancer
Precision BioSciences, a genome editing Duke spin-out, was founded by then-postdocs Jeff Smith and Derek Jantz (Biochemistry, SOM).
Synthetic Antibiotic Could Be Effective Against Drug-Resistant Superbugs
Decades of work by a series of Duke investigators yields new drug, patents and a startup company Valanbio Therapeutics
Clinetic Announces Series A Funding Round Led by Sopris Capital
Clinetic is a medical records Duke start-up founded on technology developed by a team at the Duke Institute for Health Innovation
Newly Identified Lipid in Breast Milk Might Reduce Cerebral Palsy in Infants
Tellus Therapeutics, a neonatal white matter injury therapeutics start-up, was co-founded by Dr. Eric Brenner (Pediatrics, SOM)
Minutia, Oregon Health & Sciences University and Go Pen Win First-Ever American Diabetes Association Innovation Challenge
Minutia is a next generation cell therapy start-up co-founded by cell sensing luminary Professor Tuan Vo-Dinh (BME, Pratt).
How a Duke Professor and Two Duke Ph.D.s are Building an AI Drug Discovery Start-Up
Duke Professor Bruce Donald and his former students are combining computer science, structural biology, and an entrepreneurial spirit to design new drugs at Ten63 Therapeutics.